Related Experiment Video
Updated: May 16, 2026
11:24
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
Published on: February 10, 2018
Encephalopathy and liver transplantation
1Liver Unit, Hospital Vall Hebron, Barcelona, Spain. laia.chavarria@vhir.org
Metabolic Brain Disease
|November 17, 2012
Summary
Liver transplantation (LT) can improve cognitive function in patients with hepatic encephalopathy (HE). However, pre-existing neurological comorbidities and persistent HE can impact long-term cognitive outcomes after LT.
Area of Science:
- Neuroscience
- Hepatology
- Medical Imaging
Background:
- Liver transplantation (LT) candidates often have hepatic encephalopathy (HE) and neurological comorbidities affecting cognition.
- Differentiating the impact of HE versus comorbidities is crucial for assessing neurological benefits post-LT.
Purpose of the Study:
- To evaluate the role of hepatic encephalopathy and comorbidities in cognitive impairment before and after liver transplantation.
- To determine the neurological benefits and long-term cognitive outcomes following liver transplantation.
Main Methods:
- Utilized magnetic resonance imaging (MRI) and spectroscopy to assess the impact of liver failure and comorbidities.
- Reviewed patient data to analyze cognitive function pre- and post-LT, considering factors like HE, comorbidities, diabetes, and alcohol consumption.
Main Results:
- Cognitive function often recovers after LT in patients with HE.
- Persistent HE, pre-existing conditions like diabetes mellitus and alcohol use, and post-LT complications can lead to persistent or worsening cognitive deficits.
- Vascular risk factors may negatively impact long-term cognitive function after LT.
Conclusions:
- Neuroimaging aids in assessing cognitive impact in LT candidates.
- While LT can improve cognition, careful management of HE and comorbidities is essential for optimal neuropsychological outcomes.
- Long-term cognitive health post-LT requires monitoring for persistent deficits and vascular risk factors.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...